Harnessing Bacterial Extracellular Vesicle Immune Effects for Cancer Therapy

Area of Science:

• Microbiology
• Immunology
• Oncology

Background:

• Growing evidence links the human microbiome to cancer states and treatment outcomes.
• Bacterial extracellular vesicles (bEVs) are bioactive nanoparticles with roles in host-microbe interactions.
• bEVs are being explored as novel cancer immunotherapeutics.

Purpose of the Study:

• To review the immunologic effects of bEVs in cancer therapy.
• To highlight the development of native and engineered bEVs for cancer treatment.
• To discuss challenges in translating bEVs to clinical application.

Main Methods:

• Literature review of bEV interactions with host cells.
• Focus on immunologic mechanisms of bEVs.
• Analysis of preclinical and ongoing development efforts.

Main Results:

• bEVs possess intrinsic immunomodulatory properties.
• Both native and engineered bEVs show potential as cancer immunotherapeutics, vaccines, and drug delivery systems.
• Early results indicate promising applications for microbe-inspired therapies.

Conclusions:

• bEVs offer a versatile platform for next-generation cancer therapies.
• Significant challenges remain in preclinical to clinical translation, including pharmacology, toxicology, and manufacturing.
• Further research is crucial to overcome these hurdles for successful human application.